These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
741 related articles for article (PubMed ID: 28294980)
1. MicroRNA-146b: A Novel Biomarker and Therapeutic Target for Human Papillary Thyroid Cancer. Chou CK; Liu RT; Kang HY Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28294980 [TBL] [Abstract][Full Text] [Related]
2. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400 [TBL] [Abstract][Full Text] [Related]
3. Associations of miR-146a and miR-146b expression and clinical characteristics in papillary thyroid carcinoma. Sun M; Fang S; Li W; Li C; Wang L; Wang F; Wang Y Cancer Biomark; 2015; 15(1):33-40. PubMed ID: 25524940 [TBL] [Abstract][Full Text] [Related]
4. IRAK1, a Target of miR-146b, Reduces Cell Aggressiveness of Human Papillary Thyroid Carcinoma. Chou CK; Chi SY; Huang CH; Chou FF; Huang CC; Liu RT; Kang HY J Clin Endocrinol Metab; 2016 Nov; 101(11):4357-4366. PubMed ID: 27533309 [TBL] [Abstract][Full Text] [Related]
5. MicroRNAs miR-146-5p and let-7f as prognostic tools for aggressive papillary thyroid carcinoma: a case report. Geraldo MV; Fuziwara CS; Friguglieti CU; Costa RB; Kulcsar MA; Yamashita AS; Kimura ET Arq Bras Endocrinol Metabol; 2012 Nov; 56(8):552-7. PubMed ID: 23295297 [TBL] [Abstract][Full Text] [Related]
6. Association of BRAF V600E Mutation and MicroRNA Expression with Central Lymph Node Metastases in Papillary Thyroid Cancer: A Prospective Study from Four Endocrine Surgery Centers. Han PA; Kim HS; Cho S; Fazeli R; Najafian A; Khawaja H; McAlexander M; Dy B; Sorensen M; Aronova A; Sebo TJ; Giordano TJ; Fahey TJ; Thompson GB; Gauger PG; Somervell H; Bishop JA; Eshleman JR; Schneider EB; Witwer KW; Umbricht CB; Zeiger MA Thyroid; 2016 Apr; 26(4):532-42. PubMed ID: 26950846 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Lee JC; Zhao JT; Clifton-Bligh RJ; Gill A; Gundara JS; Ip JC; Glover A; Sywak MS; Delbridge LW; Robinson BG; Sidhu SB Cancer; 2013 Dec; 119(24):4358-65. PubMed ID: 24301304 [TBL] [Abstract][Full Text] [Related]
8. New global analysis of the microRNA transcriptome of primary tumors and lymph node metastases of papillary thyroid cancer. Saiselet M; Gacquer D; Spinette A; Craciun L; Decaussin-Petrucci M; Andry G; Detours V; Maenhaut C BMC Genomics; 2015 Oct; 16():828. PubMed ID: 26487287 [TBL] [Abstract][Full Text] [Related]
9. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Yip L; Kelly L; Shuai Y; Armstrong MJ; Nikiforov YE; Carty SE; Nikiforova MN Ann Surg Oncol; 2011 Jul; 18(7):2035-41. PubMed ID: 21537871 [TBL] [Abstract][Full Text] [Related]
10. miR-146a and miR-146b in the diagnosis and prognosis of papillary thyroid carcinoma. Qiu Z; Li H; Wang J; Sun C Oncol Rep; 2017 Nov; 38(5):2735-2740. PubMed ID: 29048684 [TBL] [Abstract][Full Text] [Related]
12. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells. Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA miR-146b-5p regulates signal transduction of TGF-β by repressing SMAD4 in thyroid cancer. Geraldo MV; Yamashita AS; Kimura ET Oncogene; 2012 Apr; 31(15):1910-22. PubMed ID: 21874046 [TBL] [Abstract][Full Text] [Related]
14. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Peng Y; Li C; Luo DC; Ding JW; Zhang W; Pan G Molecules; 2014 Aug; 19(8):11586-99. PubMed ID: 25100252 [TBL] [Abstract][Full Text] [Related]
15. Down-regulation of 14q32-encoded miRNAs and tumor suppressor role for miR-654-3p in papillary thyroid cancer. Geraldo MV; Nakaya HI; Kimura ET Oncotarget; 2017 Feb; 8(6):9597-9607. PubMed ID: 28030816 [TBL] [Abstract][Full Text] [Related]
16. [Expression of microRNA-221 and IL-17 in papillary thyroid carcinoma and correlation with clinicopathologic features]. Jiang XL; Zhang H; Chen YL; Peng L Zhonghua Bing Li Xue Za Zhi; 2017 Mar; 46(3):160-165. PubMed ID: 28297755 [No Abstract] [Full Text] [Related]
17. MicroRNA Expression and Association with Clinicopathologic Features in Papillary Thyroid Cancer: A Systematic Review. Aragon Han P; Weng CH; Khawaja HT; Nagarajan N; Schneider EB; Umbricht CB; Witwer KW; Zeiger MA Thyroid; 2015 Dec; 25(12):1322-9. PubMed ID: 26414548 [TBL] [Abstract][Full Text] [Related]
18. Cyto-Histological Profile of MicroRNAs as Diagnostic Biomarkers in Differentiated Thyroid Carcinomas. Matos ML; Pinto M; Alves M; Canberk S; Gonçalves A; Bugalho MJ; Papoila AL; Soares P Genes (Basel); 2024 Mar; 15(3):. PubMed ID: 38540448 [TBL] [Abstract][Full Text] [Related]
19. Clinical pathological impacts of microRNAs in papillary thyroid carcinoma: A crucial review. Chruścik A; Lam AK Exp Mol Pathol; 2015 Dec; 99(3):393-8. PubMed ID: 26321247 [TBL] [Abstract][Full Text] [Related]